Corvex Management Lp

#### I. Institutional Overview Keith Meister, the founder and Managing Partner of Corvex Management LP, represents a specific and formidable breed of institutional investor: the constructive activist. As a former protégé of the legendary Carl Icahn, Meister has refined a strategy that blends deep fundamental value analysis with a proactive approach to corporate governance. The 13F filing for the fourth quarter of 2025 reveals a portfolio that is both a testament to this high-conviction philosophy and a strategic roadmap for navigating a complex, late-cycle market environment. With a reported portfolio value of approximately **$3.01 billion** and a concentrated holding of only **23 stocks**, Corvex Management operates with a "quality over quantity" mandate that demands each position contribute significantly to the overall performance. The scale of Corvex, while smaller than the multi-billion-dollar "mega-funds," allows for a level of agility and focus that is often lost in larger institutions. A portfolio value of $3.01 billion spread across 23 names results in an average position size of roughly **$130 million**, suggesting that Keith Meister is not interested in "tracking" the market. Instead, he is making significant bets on specific corporate outcomes, management turnarounds, and industry-wide shifts. The stability in the number of holdings (23) compared to previous periods indicates a period of consolidation and refinement rather than aggressive expansion or panicked contraction. This is the portrait of an institution that is comfortable with its current "war chest" and is focusing its intellectual capital on optimizing its existing core positions. Analyzing the concentration through the lens of the `number_of_stocks` field, we see a fund that is exceptionally concentrated. In the world of institutional investing, holding fewer than 30 stocks is a signal of extreme conviction. This concentration implies that Corvex is willing to endure higher idiosyncratic risk in exchange for the potential of outsized alpha. For Meister, the goal is not to diversify away risk but to manage it through exhaustive due diligence and, in many cases, direct engagement with the boards and management teams of the companies he owns. This "psychological portrait" of Corvex in Q4 2025 is one of a disciplined predator—waiting for the right moment to increase stakes in proven winners while ruthlessly pruning "dead wood" that no longer fits the activist or value thesis. Furthermore, the portfolio's composition suggests a nuanced shift in Meister's market outlook. While the fund maintains a massive footprint in Healthcare and Life Sciences—sectors often viewed as defensive—the specific companies held (like Illumina and GeneDx) are high-growth, high-volatility technology plays within that space. This indicates that Corvex is not merely seeking safety but is looking for "growth at a reasonable price" (GARP) within sectors that have structural tailwinds. The institutional scale, combined with this concentrated, activist-driven style, positions Corvex as a "smart money" bellwether for specific themes, particularly in genomics, media restructuring, and utility-scale value unlocking. In summary, Corvex Management in Q4 2025 remains a highly focused, activist-led vehicle that prioritizes deep-value conviction over broad market exposure, signaling a belief that in the current market, individual stock selection and corporate governance intervention are the primary drivers of wealth creation. #### II. Sector Allocation Analysis The sector allocation of Corvex Management in Q4 2025 provides a profound window into Keith Meister’s macro-strategic thinking. By examining the weights assigned to various industries, we can infer a judgment on the current economic cycle, the interest rate environment, and the sectors most ripe for activist-driven value creation. **Table 2.1: Sector Allocation and Weights** | Sector | Weight (%) | Relative Concentration | | :--- | :--- | :--- | | **Healthcare** | **32.52** | Dominant Core | | **Consumer Discretionary** | **19.64** | Primary Offensive | | **Utilities** | **14.65** | Defensive Value | | **Communication Services** | **14.58** | Strategic Growth | | **Industrials** | **9.68** | Cyclical Exposure | | **Technology** | **5.64** | Selective Tech | | **Materials** | **3.29** | Tactical Hedge | | **Consumer Staples** | **0.00** | Complete Avoidance | The most striking feature of the Corvex portfolio is the **32.52% allocation to Healthcare**. However, a deeper look reveals that this is not a broad-based bet on "Big Pharma" or hospitals. Instead, it is a highly concentrated bet on the **Genomics and Diagnostics** sub-sector, represented by massive positions in **ILMN (Illumina)** and **WGS (GeneDx)**. The concentration in the top three sectors (Healthcare, Consumer Discretionary, and Utilities) totals a staggering **66.81%**. This indicates a fund that is "overweight" on its best ideas, a classic hallmark of activist investing. When an institution puts one-third of its capital into a single sector, it is signaling a belief in a structural transformation within that industry that the broader market may be mispricing. The **Consumer Discretionary (19.64%)** and **Communication Services (14.58%)** allocations should be viewed as a combined "Experience and Media" theme. With significant holdings in **AMZN (Amazon)**, **DIS (Disney)**, and **MGM (MGM Resorts)**, Meister is betting on the resilience of the high-end consumer and the successful restructuring of legacy media assets. The increase in Disney's weight this quarter is particularly telling, suggesting that Corvex sees the "streaming wars" entering a more profitable phase and the "parks and experiences" segment as a durable cash-flow engine. The **Utilities (14.65%)** allocation, primarily driven by **SWX (Southwest Gas)**, serves as the portfolio's "ballast." In an environment of fluctuating interest rates, utilities offer a combination of yield and regulatory certainty. However, for an activist like Meister, utilities are often "sum-of-the-parts" plays. The presence of SWX suggests that Corvex is still focused on the potential for asset divestitures or structural changes within the utility space to unlock shareholder value. Interestingly, the **Technology (5.64%)** weight is relatively low compared to the S&P 500's heavy tech weighting. This "underweight" position in traditional tech (software, semiconductors) suggests that Meister finds better risk-adjusted returns in "tech-enabled" sectors like Healthcare/Genomics or in specific turnaround stories rather than chasing the high-valuation AI momentum that dominated much of 2024 and 2025. This is a contrarian stance that prioritizes valuation discipline over momentum. The **Industrials (9.68%)** sector, featuring **UNP (Union Pacific)** and **VSTS (Vestis)**, provides exposure to the "real economy." Union Pacific, as a dominant rail carrier, is a bet on the long-term efficiency of North American logistics, while Vestis represents a niche industrial services play. These holdings suggest that while Meister is aggressive in his top picks, he maintains a foundation of companies with high barriers to entry and "moats" that can withstand inflationary pressures. From a macro perspective, the total absence of **Consumer Staples (0%)** is a bold statement. It suggests that Corvex finds the "defensive growth" of staples to be overvalued or lacking the catalysts necessary for an activist strategy. Meister is clearly favoring sectors where he can influence the outcome (Healthcare, Utilities, Media) over sectors that are purely driven by macro-consumer trends. In conclusion, the sector layout of Corvex Management in Q4 2025 reveals a "Barbell Strategy." On one end, there is high-octane, high-conviction exposure to the future of medicine (Healthcare/Genomics). On the other end, there is a solid foundation of cash-generative, asset-heavy businesses (Utilities, Industrials, and Media). This allocation reflects a judgment that the market is in a "stock-picker's" phase, where broad sector trends are less important than the specific idiosyncratic catalysts within each company. Meister is not betting on the economy as a whole; he is betting on his ability to identify and unlock value in specific, high-potential corners of the market. #### III. Top 10 Holdings Deep Dive The Top 10 holdings of Corvex Management represent the "engine room" of the fund, accounting for the vast majority of its assets and its potential for outperformance. In Q4 2025, these ten positions comprise the core of Keith Meister’s investment thesis. **Table 3.1: Top 10 Holdings Detail** | Rank | Ticker | Company Name | Market Value | Weight (%) | Qtr Change | Weight Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 1 | **ILMN** | Illumina, Inc. | $502,291,385 | 15.35 | 0% | +3.29 | | 2 | **SWX** | Southwest Gas Holdings | $402,545,091 | 12.30 | 0% | -0.77 | | 3 | **WGS** | GeneDx Holdings Corp. | $397,805,288 | 12.16 ---